[direct reporting network Beijing on November 29th news] (an online) the provincial food and drug administration before the date of release drug unqualified information bulletin, 8 batches of substandard medicines, problems involving load difference, visible foreign matter. On the issue of drugs and related units, food and drug administration departments are investigating.

Involving substandard medicines labeled Baicheng Yizheng Pharmaceutical Company Limited production of six Dihuang capsules, 20150307 batches; Qianzhi capsules, Gansu Fuzheng pharmaceutical production batch J20151009 Polytron Technologies Inc; Tonghua Maoxiang Pharmaceutical Co. Ltd. production of Keteling capsule group, No. 150301; Wuhu Kangqi Pharmaceutical Co. Ltd production of Bupivacaine Hydrochloride Injection, lot 14111909 Huayi (Hebei); China Pharmaceutical Co. Ltd production of Weikangling capsule, number 150401; Bozhou City Bai Shi letter Chinese herbal medicine limited production of 150901 batches of uncaria, motherwort particles, Foren; Gansu Pharmaceutical Technology Co. Ltd. production batch number 150803; Shandong eakan pharmaceutical Limited by Share Ltd production of Cefalexin Granules, lot 1503012. Provincial Food and drug administration to remind the public that the purchase of medicines to the pharmaceutical retail enterprise medical institutions or legal, not only to look at whether there is a pharmacy drug business license, but also pay attention to the drug approval number, and ask for the bill. Such as the purchase of a suspected counterfeit drugs or found substandard drugs to be informed in the market, please dial "12331" hotline to report complaints.